Peptides DB
Research-centric peptide and protocol reference hub
Study 68 of 68HGH (Somatropin) literatureThe New England journal of medicineTop journal2026

Advances in Systemic Treatment of Breast Cancer.

Not reported in abstract.

Read at The New England journal of medicineAdd to compare

Where it sits

this study against the rest of the hgh (somatropin) corpus
4
Preclinical · this one
47
Observational
0
Open-label
10
Randomised
7
Reviews

Summary and findings

Not reported in abstract.

How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the HGH (Somatropin) corpus

BConverging Growth Trajectories During Recombinant Human Growth Hormone Therapy in Children With Isolated and Combined Pituitary Hormone Deficiency.Clinical endocrinology · 2023 · n=120 · Cumulative height SDS gains after 48 months: 3.10 ± 1.36 for CPHD vs. 1.92 ± 0.87 for IGHD, p < 0.001.HumanBMicrostructural Vulnerability of the Tibial Tubercle Apophysis During Growth Hormone Therapy: A Multicenter Prospective Cohort Study Using Diffusion Tensor Imaging-MRI.The Journal of bone and joint surgery. American volume · 2023 · n=53 · ADC was significantly higher at 8 months compared with baseline (1.61 × 10-3 vs 1.52 × 10-3 mm2/sec, p = 0.041).HumanBA Novel ACAN Missense Variant in the G1 Domain Causes Short Stature, Advanced Bone Age, and Osteochondritis Dissecans: A Case Report and Literature Review.Clinical genetics · 2023 · n=1 · Not reported in abstract.HumanAInteraction between vitamin D and the growth hormone/insulin-like growth factor 1 axis in children: a systematic review and meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026 · WMD: 5.83 ng/mL increase in vitamin D levels after rhGH treatment, 95% CI: 3.72 to 7.94, p<0.00001.reviewDInteraction between vitamin D and the growth hormone/insulin-like growth factor 1 axis in children: a systematic review and meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026 · WMD: 5.83 ng/mL increase in vitamin D levels after rhGH treatment, 95% CI: 3.72 to 7.94, p<0.00001.reviewBA Novel ACAN Missense Variant in the G1 Domain Causes Short Stature, Advanced Bone Age, and Osteochondritis Dissecans: A Case Report and Literature Review.Clinical genetics · 2026 · Not reported in abstract.Human